期刊文献+

皮肤出血点、发热、神志改变1例

下载PDF
导出
摘要 1病历摘要 患者,女,40岁,主因“发现全身皮肤出血点3天”于本院血液科门诊就诊,查血常规:白细胞(WBC)4.32×10^9/L,N0.558,血红蛋白(HGB)102g/L,血小板(PLT)8×10^9/L,遂转至本院急诊治疗。
作者 李振华
出处 《中国医刊》 CAS 2014年第11期18-20,共3页 Chinese Journal of Medicine
  • 相关文献

参考文献10

  • 1Moake J. Thrombotic microangiopathies : multimers, metalloprotease, and beyond [ J ]. Clin & Trans sci, 2009,2 (5) :366-373.
  • 2郑昌成,吴竞生.血栓性血小板减少性紫癜的诊治现状与进展[J].中华血液学杂志,2011,32(9):645-648. 被引量:27
  • 3刘芳,BF Hendrik,董宁征,白霞,V Karen,D Hans,阮长耿.血栓性血小板减少性紫癜患者vWF裂解蛋白酶抗原和活性的检测及意义[J].中华血液学杂志,2006,27(3):154-157. 被引量:10
  • 4Nguyen TC, Han YY. Plasma exchange therapy for thrombotic mi- croangiopathies [ J]. Organogenesis,2011,7( 1 ) :28-31.
  • 5Kim JW, Kim I, Oh KH, et al. Therapeutic plasma exchange in patients with thrombotic thrombocytopenie purpura-hemolytic uremic syndrome:the 10-year experience of a single center [ J]. Hematology, 2011,16(2) :73-79.
  • 6崔静,朱铁楠,赵永强,张奉春.系统性红斑狼疮合并血栓性血小板减少性紫癜14例临床分析[J].中华内科杂志,2013,52(5):383-386. 被引量:10
  • 7蔡奕峰,滕鎔,施文喻,秦燕,尤学芬,徐瑞容.血浆置换治疗血栓性血小板减少性紫癜13例[J].中国危重病急救医学,2009,21(8):509-509. 被引量:4
  • 8Marie Scully, Beverley J. Hunt, Sylvia Benjamin ect ; Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpu- ra and other thrombotic microangiopathies [ J ]. British Journal of Haematology ,2012,158 ( 3 ) :323-335.
  • 9George JN. Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura [ J]. Am J Hematol, 2012,87 ( Suppl 1 ) :S88-S91.
  • 10Deng MY, Zhang GS, Zhang Y, et al. Analysis of clinical and labo- ratory characteristics in 42 patients with thrombotic thrombocytopenic purpura from a single center in China [ J ]. Trans & Apher Sci, 2013,49 (3) :447-452.

二级参考文献35

  • 1刘芳,金洁,董宁征,王云贵,阮长耿.一例两种新的ADAMTS13基因突变导致的遗传性血栓性血小板减少性紫癜[J].中华血液学杂志,2005,26(9):521-524. 被引量:11
  • 2卢勇,秦伟毅,苏磊,童华生,钱洪津,吴恒义.血浆置换在急性肝功能障碍中的临床应用研究——单一脏器功能障碍与MODS的比较[J].中国危重病急救医学,2007,19(7):431-432. 被引量:3
  • 3Iwai H, Nagaki M, Naito T, et al. Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure. Crit Care Med, 1998,26 (5) :873-876.
  • 4Rock G. The management of thrombotic thrombocytopenic purpura in 2005. Semi Thromb Hemost, 2005, 31 ( 6 ) : 709-716.
  • 5Yomtovian R, Niklinski W, Silver B, et al. Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature. Br J Haematol, 2004, 124 (fi): 787-795.
  • 6Furlan M,Robles R,Lamie B.Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis.Blood,1996,87:4223-4234.
  • 7Tsai HM.Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion.Blood,1996,87:4235-4244.
  • 8Zheng X,Chung D,Takayama TK,et al.Structure of von Willebrand factor-cleaving protease (ADAMTS13),a metalloprotease involved in thrombotic thrombocytopenic purpura.J Biol Chem,2001,276:41059-41063.
  • 9Fujikawa K,Suzuki H,McMullen B,et al.Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family.Blood ,2001,98:1662-1666.
  • 10Rick ME,Molls S,Taylor MA.Clinical use of a rapid collagen binding assay for yon Willebrand factor cleaving protease in patients with thrombotic thrombocytopenic purpura.Thromb Haemost,2002,88:598-604.

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部